During the past decade, Primary Care Research Group conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Primary Care Research Group" #1 sponsor was "Axcella Health, Inc" with 1 trials, followed by "Intarcia Therapeutics" with 1 trials sponsored, "Marius Pharmaceuticals" with 1 trials sponsored, "Mizkan Holdings Co., Ltd." with 1 trials sponsored and "Plethora Solutions Ltd" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Primary Care Research Group" #1 collaborator was "Endothelix" with 1 trials as a collaborator, "ObvioHealth" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Primary Care Research Group" are "Anemia, Sickle Cell" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Hypogonadism, Male" (1 trials), "Prehypertension" (1 trials) and "Premature Ejaculation" (1 trials). Many other conditions were trialed in "Primary Care Research Group" in a lesser frequency.

Most popular intervention types in "Primary Care Research Group" are "Drug" (3 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "AXA4010" (1 trials), "AndroGel" (1 trials), "Empagliflozin (oral)" (1 trials), "Glimepiride (oral)" (1 trials) and "ITCA 650 20/60 mcg/day" (1 trials). Other intervention names were less common.

The vast majority of trials in "Primary Care Research Group" are 3 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Primary Care Research Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Primary Care Research Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Primary Care Research Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".